Couragene
PrivateLast Round
Grant
Sep 19, 2024
Total Funding Raised
$42.94M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Couragene operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Grant round in September 2024.
Couragene is a biotechnology company that develops gene and biologic therapies using its proprietary Stimuli-responsive Traceless Engineering Platform (STEP) for the delivery of genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Couragene Comparables
Compare Couragene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Code Biotherapeutics | 86% | |
| Nanite, Inc. | 85% | |
| CyGenica | 83% |
For institutional investors. Book with your work email.
Couragene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 19, 2024 | ||||
| Grant | Oct 10, 2023 | ||||
| Seed | Sep 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Couragene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hi2 Global | Seed |
| Foothill Ventures | Seed |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 46% MoM, reaching 1.7K.
- Jun 21, 2026
Monthly visitors grew 1047% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Couragene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Couragene's valuation, stock price, and market status.
Is Couragene a public or private company?
Couragene is a private company.
What is the current stock price of Couragene?
Couragene is a private company, so its shares have no public market price. Caplight tracks Couragene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Couragene worth (valuation)?
Valuation information for Couragene is not publicly available.
Can I buy Couragene stock?
Couragene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Couragene's last funding round?
Couragene's most recent funding round was Grant on September 19, 2024.
Who are the main investors in Couragene?
Key investors in Couragene include Hi2 Global, Foothill Ventures, National Institute of Neurological Disorders and Stroke.
Will Couragene IPO soon?
No public IPO plans have been announced for Couragene.
How can I track Couragene secondary market activity?
Caplight tracks bids, offers, and trades in Couragene's shares on secondary markets.